Liberty Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$260K Buy
+4,286
New +$250K 0.03% 225
2025
Q1
Sell
-5,707
Closed -$323K 160
2024
Q4
$323K Buy
5,707
+914
+19% +$51.1K 0.05% 158
2024
Q3
$248K Buy
+4,793
New +$225K 0.04% 177
2024
Q2
Sell
-4,217
Closed -$229K 234
2024
Q1
$229K Buy
+4,217
New +$215K 0.04% 170
2023
Q3
Sell
-3,394
Closed -$217K 175
2023
Q2
$217K Buy
3,394
+11
+0.3% +$738 0.05% 173
2023
Q1
$234K Buy
+3,383
New +$239K 0.05% 199
2022
Q3
$276K Sell
3,891
-446
-10% -$32.4K 0.07% 116
2022
Q2
$334K Sell
4,337
-337
-7% -$25.7K 0.14% 103
2022
Q1
$341K Buy
4,674
+54
+1% +$3.63K 0.12% 99
2021
Q4
$288 Sell
4,620
-745
-14% -$43.7K 0.01% 127
2021
Q3
$317K Sell
5,365
-838
-14% -$55.2K 0.11% 110
2021
Q2
$415K Sell
6,203
-674
-10% -$43.9K 0.16% 79
2021
Q1
$427K Hold
6,877
0.21% 68
2020
Q4
$427K Buy
6,877
+1,910
+38% +$117K 0.21% 68
2020
Q3
$299K Buy
4,967
+637
+15% +$38.3K 0.18% 73
2020
Q2
$255K Sell
4,330
-136
-3% -$8.13K 0.18% 79
2020
Q1
$249K Sell
4,466
-197
-4% -$12K 0.22% 71
2019
Q4
$299K Buy
4,663
+1,140
+32% +$65.3K 0.24% 80
2019
Q3
$179K Sell
3,523
-1,844
-34% -$86.7K 0.17% 102
2019
Q2
$243K Buy
5,367
+1,933
+56% +$90K 0.21% 93
2019
Q1
$163K Buy
3,434
+79
+2% +$3.94K 0.12% 99
2018
Q4
$174K Buy
+3,355
New +$180K 0.13% 91

Other funds holding BMY

Liberty Wealth Management's BMY Position: Q1 2026 in Review

Liberty Wealth Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 4,286 shares worth $260K. The stake represents 0.03% of the portfolio and ranks #225 among its holdings. This is a return to the name: Liberty Wealth Management previously reported a position in BMY as recently as Q4 2024.

Liberty Wealth Management first reported a position in BMY in Q4 2018 and has held it in 22 quarters since. The position peaked at $427K in Q1 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Liberty Wealth Management held 4,286 shares of Bristol-Myers Squibb worth $260K as of Q1 2026.
  • Bristol-Myers Squibb was a new Liberty Wealth Management position in Q1 2026.
  • Bristol-Myers Squibb made up 0.03% of Liberty Wealth Management's portfolio in Q1 2026, its #225 holding.
  • Liberty Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 22 quarters since.
  • Liberty Wealth Management's Bristol-Myers Squibb position peaked at $427K in Q1 2021.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Liberty Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.